Translation of Antivirals & Immunostimulants in HBV: From Bench to Bedside

Time: 3:30 pm
day: Day One


• Characterizing the anti-HBV immune response in preclinical studies and understanding mechanisms of viral replication

• Assessing the interplay between viral replication and the immune response

• Translating learnings to clinical trials and establishing synergistic combination regimens